FDA recalls birth control due to packaging issue


    The FDA issued a voluntary recall of birth control due to a packaging issue that may affect the dosage of the medication. (Food and Drug Administration)

    The Food and Drug Administration issued a voluntary recall of birth control due to a packaging issue that may affect the dosage of the medication.

    Four types of birth control made by Apotex Corp. are directly being recalled due to incorrect tablet arrangements and/or empty blister pockets.

    The birth control medications affected are Drospirenone and Ethinyl Estradiol Tablets with the following lot numbers:

    • 7DY008A
    • 7DY009A
    • 7DY0010A
    • 7DY0011A

    According to the FDA, when a patient does not take a tablet due to a missing tablet or that a patient takes a placebo instead of an active tablet, loss of efficacy is possible due to variation in the dosage consumed.

    To date, no case has been reported for pregnancy and adverse event to Apotex. Patients who have received impacted lots of Drospirenone and Ethinyl Estradiol Tablets, USP 3MG/0.03MG. or have questions regarding this recall please contact your pharmacy.

    Individuals should not interrupt their therapy, use a non-hormonal method of birth control, contact their health care provider for medical advice and may return the impacted packages to their pharmacist.

    Consumers with questions regarding this recall can contact Apotex corp. by phone-number 1-800-706-5575 (8:30am – 5:00pm, EST Monday thru Friday) or email address UScustomerservice@Apotex.com .

    Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

    News In Photos

      Loading ...